Back to company

ENKAM PHARMACEUTICALS ApS: Financial statements 2014

CVR: 25812921

ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,669,049 and a net result of DKK 2,812,225 compared with DKK -3,665,105 the year before. Equity amounted to DKK -1,918,271.

Gross Profit
4,669,049 kr.
Profit/Loss
2,812,225 kr.
Equity
-1,918,271 kr.
Total Assets
1,281,268 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-4.7 mio.2.8 mio.-1.9 mio.-
2013--2.6 mio.-3.7 mio.-4.7 mio.-
2012--1.1 mio.-2.5 mio.-3.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ENKAM PHARMACEUTICALS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

ENKAM PHARMACEUTICALS ApS: The 2013 annual report is outJun 4, 2014

ENKAM PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK -2,621,140, and the net result was DKK -3,665,105.

About ENKAM PHARMACEUTICALS ApS

ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 0 employees. In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity amounted to DKK -1,179,474.

Other financial years